Land: Ástralía
Tungumál: enska
Heimild: Department of Health (Therapeutic Goods Administration)
prochlorperazine mesilate, Quantity: 12.5 mg/mL
Sanofi-Aventis Australia Pty Ltd
prochlorperazine mesilate
Injection
Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride
Intramuscular
10 x 1 mL
(S1) This Schedule is intentionally blank
STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.
Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2007-07-16